Frag' FlorenceEvidenz. Klar. Anwendbar.
Uhr 7/8Sources Journal Tree
Easy Demo

Lokaler Crossref-Datenbestand · journal-article

Association of HTR2A (rs6313) gene polymorphism with autism spectrum disorder in Jordanian children: a case-control study

Wiam Khalil, Elaf Adel Al-Dalabeeh, Malek Zihlif

Drug Metabolism and Personalized Therapy · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract Objectives Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with a significant genetic component, often linked to disruptions in the serotonergic system. The HTR2A gene, specifically the rs6313 (102T>C) polymorphism, is a primary candidate for investigating ASD susceptibility. The aim of this study is to investigate the association of rs6313 polymorphism with susceptibility to ASD in the Jordanian population. Methods In this case-control study, 99 Jordanian children with ASD and 109 neurotypical controls were genotyped using PCR-RFLP. Genotype and allele frequencies were analyzed under multiple genetic models. Results No statistically significant differences were found between cases and controls regarding genotype (p=0.54) or allele frequencies (p=0.3284). The distribution adhered to Hardy-Weinberg equilibrium in both groups. Conclusions Our findings suggest no significant association between the HTR2A rs6313 and ASD susceptibility in the Jordanian population. These results emphasize the need for larger, multi-marker studies to account for regional genetic diversity.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Wiam Khalil, Elaf Adel Al-Dalabeeh, Malek Zihlif
Quelle
Drug Metabolism and Personalized Therapy
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
2363-8915
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Wiam Khalil, Elaf Adel Al-Dalabeeh, Malek Zihlif (2026). Association of HTR2A (rs6313) gene polymorphism with autism spectrum disorder in Jordanian children: a case-control study. Drug Metabolism and Personalized Therapy. https://doi.org/10.1515/dmpt-2026-0022
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1